Key result
The TAPSE/MAPSE ratio was independently associated with the occurrence of cardiogenic pulmonary edema in critically ill patients.
Why the study?
It was unknown whether the tricuspid annular systolic excursion to mitral annular systolic excursion (TAPSE/MAPSE) ratio is associated with cardiogenic pulmonary edema in critically ill patients.
Does the TAPSE/MAPSE ratio predict the occurrence of cardiogenic pulmonary edema in critically ill patients?
Observational (n=290)
No
Does the TAPSE/MAPSE ratio predict the occurrence of cardiogenic pulmonary edema in critically ill patients?
The TAPSE/MAPSE ratio is a useful echocardiographic index of right- and left-ventricular function mismatch that independently predicts the risk of cardiogenic pulmonary edema in critically ill patients.
Answers are grounded in this paper and cite their sources.
TASPE/MAPSE ratio was associated with CPE; leaves open whether ratio aids risk stratification pending prospective validation.
BACKGROUND: This study aimed to explore whether the tricuspid annular systolic excursion (TAPSE)/mitral annular systolic excursion (MAPSE) ratio was associated with the occurrence of cardiogenic pulmonary edema (CPE) in critically ill patients. MATERIALS AND METHODS: This was a prospective observational study conducted in a tertiary hospital. Adult patients admitted to the intensive care unit who were on mechanical ventilation or in need of oxygen therapy were prospectively screened for enrolment. The diagnosis of CPE was determined based on lung ultrasound and echocardiography findings. TAPSE ≥ 17 mm and MAPSE ≥ 11 mm were used as normal references. RESULTS: Among the 290 patients enrolled in this study, 86 had CPE. In the logistic regression analysis, the TASPE/MAPSE ratio was independently associated with the occurrence of CPE (odds ratio 4.855, 95% CI: 2.215-10.641, p < 0.001). The patients' heart function could be categorized into four types: normal TAPSE in combination with normal MAPSE (TAPSE↑/MAPSE↑) (n = 157), abnormal TAPSE in combination with abnormal MAPSE (TAPSE↓/MAPSE↓) (n = 40), abnormal TAPSE in combination with normal MAPSE (TAPSE↓/MAPSE↑) (n = 50) and normal TAPSE in combination with abnormal MAPSE (TAPSE↑/MAPSE↓) (n = 43). The prevalence of CPE in patients with TAPSE↑/MAPSE↓ (86.0%) was significantly higher than that in patients with TAPSE↑/MAPSE↑ (15.3%), TAPSE↓/MAPSE↓ (37.5%), or TAPSE↓/MAPSE↑ (20.0%) (p < 0.001). The ROC analysis showed that the area under the curve for the TAPSE/MAPSE ratio was 0.761 (95% CI: 0.698-0.824, p < 0.001). A TAPSE/MAPSE ratio of 1.7 allowed the identification of patients at risk of CPE with a sensitivity of 62.8%, a specificity of 77.9%, a positive predictive value of 54.7% and a negative predictive value of 83.3%. CONCLUSIONS: The TAPSE/MAPSE ratio can be used to identify critically ill patients at higher risk of CPE.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) conducted an observational in Cardiogenic pulmonary edema (CPE) (n=290). TAPSE/MAPSE ratio was evaluated on Occurrence of cardiogenic pulmonary edema (CPE) (OR 4.855, 95% CI 2.215-10.641, p=<0.001). The TAPSE/MAPSE ratio was independently associated with the occurrence of cardiogenic pulmonary edema in critically ill patients.
Synapse has enriched 10 related papers. Consider them for comparative context: